Hye Sung Moon

Hye Sung Moon

Auto-generated profile, based on publicly available information

Hye Sung Moon

Department of Nursing, Ewha Womans University Mokdong Hospital, Seoul, Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2023 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
BYBoeun Yoo
Boeun Yoo
AKArang Kim
Arang Kim
HMHye Sung Moon
Hye Sung Moon
MSMin-Kyung So
Min-Kyung So
TJTae-Dong Jeong
Tae-Dong Jeong
Jungwon HuhJungwon Huh
Jungwon Huh
Boeun Yoo, M.S., Arang Kim, M.S., Hye Sung Moon, M.S., Min-Kyung So, M.D., Ph.D., Tae-Dong Jeong, M.D., Ph.D., Kyoung Eun Lee, M.D., Ph.D., Byung-In Moon, M.D., Ph.D., and Jungwon Huh, M.D., Ph.D.. Ann Lab Med 2024;44:82-91. https://doi.org/10.3343/alm.2024.44.1.82

31 December 2023 in Korean Journal of Women Health Nursing
Verified
Journal Article
Open access
PDF file
HMHyesung Moon
Hyesung Moon
Background Approximately 36% of all cancer patients in Korea receive radiotherapy, a key modality of cancer treatment alongside surgery and chemotherapy. Diverse therapeutic techniques have resulted from advances in radiological technology and treatment devices, contributing to the improvement of the quality of treatment and patients' quality of life. According to 2022 data from the Korea Institute of Radiological Medical Sciences, 7.8% of female patients who underwent radiotherapy in 2019 received treatment for gynecologic cancer. Notably, approximately 98% of brachytherapy procedures were conducted to treat gynecologic cancer [1]. Radiotherapy for gynecologic cancer, which can involve both teletherapy and brachytherapy, plays a pivotal role in improving treatment outcomes because it targets not only the early stages of the cancer but also advanced lesions for radical, adjuvant, and palliative purposes. This article explores recent developments in radiotherapy, with a particular focus on radiotherapy for gynecologic cancer, and discusses acute and chronic adverse events that may occur during treatment, as well as interventions.